Utility of the highly immunodeficient SRG rat for combined drug efficacy, pharmacokinetics, and toxicology studies in tumor-bearing animals Kristina Celin2025-01-28T01:35:15+00:00 Read More
The SRG Rat, an immunodeficient model for orthotopic glioblastoma, diffuse intrinsic pontine glioma (DIPG) PDX, and intracranial metastatic breast cancer PDX tumors Kristina Celin2025-01-28T01:41:25+00:00 Read More
The highly immunodeficient SRG Rat for modeling diabetes Kristina Celin2025-01-21T18:49:37+00:00 Read More
Comparative pathology of the SRG rat, an immunodeficient rat model for human xenograft and toxicology studies Kristina Celin2025-01-29T01:23:15+00:00 Read More
In vivo subcutaneous and orthotopic cancer xenograft modeling in the Sprague- Dawley Rag2 null Il2rgamma null SRG rat (OncoRat®) Kristina Celin2025-01-26T06:59:09+00:00 Read More
Comparative analysis of complete blood count, serum chemistry and immunodeficient phenotype between SRG and CD rats Kristina Celin2025-01-26T07:01:00+00:00 Read More
In vivo imaging of ovarian and non-small cell lung cancer models hosted in the Sprague-Dawley Rag2 null Il2rgamma null SRG rat (OncoRat®) Kristina Celin2025-01-21T18:56:05+00:00 Read More
Sprague-Dawley Rag2 null Il2rgamma null SRG rat (OncoRat®) has enhanced tumor microenvironment in human prostate cancer xenografts Kristina Celin2025-01-21T18:56:41+00:00 Read More
The SRG OncoRat®; A Rag2/Il2rg double-knockout rat supports enhanced precision-medicine based cancer studies. Kristina Celin2025-01-21T18:57:29+00:00 Read More
The CHOlympian Platform™ Combines Transposase-Mediated Stable Integration and Cas-CLOVER Host Modification to Deliver Highly Productive CHO Cell Lines for Biotherapeutic Manufacturing The CHOlympian Platform™ Combines Transposase-Mediated Stable Integration and Cas-CLOVER Host Modification to Deliver Highly Productive CHO Cell Lines for Biotherapeutic Manufacturing Kristina Celin2024-04-23T20:29:40+00:00 Read More
